Daily News Podcast

Ezetimibe effective as primary prevention


Ezetimibe is found to be effective in lowering LDL for primary cardiovascular prevention in patients who were 75 or older. Also today, the FDA says that the benefits of paclitaxel-coated devices outweigh risks for peripheral arterial disease, flu activity is down for the second consecutive week, and a look at homelessness among LGBT youth in the United States.

Amazon Alexa

Apple Podcasts

Google Podcasts


Recommended Reading

New or existing drugs? Both fuel price inflation
MDedge Pediatrics
Courts block Trump from eroding contraceptive mandate
MDedge Pediatrics
Mandatory reporting laws
MDedge Pediatrics
Survey: Government shutdown is affecting patient health
MDedge Pediatrics
Cyberbullied by anti-vaxxers: Monique Tello Part I
MDedge Pediatrics